InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,633.91
(
1.02%
)
US TECH 100
20,112.40
(
-0.03%
)
Dow Jones
39,721.36
(
1.09%
)
Brent Oil
84.97
(
-0.10%
)
Bitcoin
58,379.25
(
1.08%
)

Replies to post #36378 on ViaDerma Inc (VDRM)

Replies to #36378 on ViaDerma Inc (VDRM)

PhenixBleu

03/21/18 10:43 AM

#36379 RE: retired early #36378

Introduction is one thing. Getting beyond the Medicare/Medicaid/VA barriers to non-FDA approved, OTC drugs with a price tag upwards of $79.00 per bottle is where the sales opportunities stop.

What doctor is going to recommend a patient buy a $79 OTC product when competitors offer options at lower price points?

They have a new sales marketing force aimed to introduce our products to select targets like veterans admin, hospitals, ect. They must have supplied free samples being spread around the world. It's going to be huge. :)

PhenixBleu

03/21/18 11:05 AM

#36381 RE: retired early #36378

Another barrier may be the fact that many in podiatry know that Keough is the person that owns the Site Specific Penetration Technology (SSPT) and won the Edison Award in 2012.

They have a new sales marketing force aimed to introduce our products to select targets like veterans admin, hospitals, ect. They must have supplied free samples being spread around the world. It's going to be huge. :)